APOE and Alzheimer disease: The longitudinal course of AD is complex and several sociodemographic and clinical factors, such as younger age or higher education [15,16], being a carrier of the apolipoprotein E (APOE) ε4 allele [17], or moderate-to-severe level of dementia [15,18] have been suggested to increase the rate of cognitive decline in untreated patients.